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Gainesville, FloridaABSTRACT Pulmonary surfactant protein B (SP-B) is an essential protein for lowering surface tension in the alveoli. SP-B1-25,
a peptide comprised of the N-terminal 25 amino-acid residues of SP-B, is known to retain much of the biological activity of SP-B.
Circular dichroism has shown that when SP-B1-25 interacts with negatively charged lipid vesicles, it contains significant helical
structure for the lipid compositions and peptide/lipid ratios studied here. The effect of SP-B1-25 on lipid organization and poly-
morphisms was investigated via DSC, dynamic light scattering, transmission electron microscopy, and solid-state NMR spec-
troscopy. At 1-3 mol% peptide and physiologic temperature, SP-B1-25 partitions at the interface of negatively charged PC/PG
lipid bilayers. In lipid mixtures containing 1-5 mol% peptide, the structure of SP-B1-25 remains constant, but
2H and 31P NMR
spectra show the presence of an isotropic lipid phase in exchange with the lamellar phase below the Tm of the lipids. This
behavior is observed for both DPPC/POPG and POPC/POPG lipid mixtures as well as for both the PC and PG components
of the mixtures. For 1-3 mol% SP-B1-25, a return to a single lamellar phase above the lipid mixture Tm is observed, but for
5 mol% SP-B1-25 a significant isotropic component is observed at physiologic temperatures for DPPC and exchange broadening
is observed in 2H and 31P NMR spectra of the other lipid components in the two mixtures. DLS and TEM rule out the formation of
micellar structures and suggest that SP-B1-25 promotes the formation of a fluid isotropic phase. The ability of SP-B1-25 to fuse
lipid lamellae via this mechanism, particularly those enriched in DPPC, suggests a specific role for the highly conserved
N-terminus of SP-B in the packing of lipid lamellae into surfactant lamellar bodies or in stabilizing multilayer structures at the
air-liquid interface. Importantly, this behavior has not been seen for the other SP-B fragments of SP-B8-25 and SP-B59-80, indi-
cating a critical role for the proline rich first seven amino acids in this protein.INTRODUCTIONPulmonary surfactant (PS) is a lipid-rich substance contain-
ing key proteins that minimizes surface tension in the
alveoli. PS is required for normal respiration and provides
a barrier against disease (1–3). PS is synthesized, processed
into lamellar bodies, secreted, and recycled by type II epi-
thelial cells, which cover ~5% of the alveolar gas exchange
surface. PS lipids undergo a cycle of adsorption and resorp-
tion from the fluid subphase to maintain a surface-active
layer at the alveolar air-fluid interface, with lung surfactant
being completely recycled every 5–10 h (4).
Mammalian PS has a highly conserved lipid composition
dominated by zwitterionic PCs (70–80%) and anionic PG
and PI (10–20%) (5,6). Approximately 50% of the PC lipids
and almost all of the anionic lipids in lung surfactant areSubmitted April 28, 2010, and accepted for publication June 28, 2010.
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0006-3495/10/09/1773/10 $2.00monounsaturated. However, a significant fraction of PS
(>40% of the lipids) is fully saturated DPPC, and this com-
ponent is conserved among mammalian species. DPPC
enhances the stability of lipid monolayers at air-water inter-
faces, which is of particular relevance to lung function.
However, the lipid composition of PS alone is not sufficient
to maintain the organization and dynamics of the lipid
assemblies observed in the lung surfactant fluid of intact
lung tissue. It has been postulated that protein-induced lipid
polymorphisms and protein-induced trafficking of lipids to
the interface are critical for PS function at ambient pressure
(7–10). To support this claim, it has been shown that surfac-
tant proteins B and C (SP-B and SP-C, respectively), which
are highly hydrophobic and present at relatively low levels,
are essential for imparting the recycling properties of LS.
In particular, surfactant protein B (SP-B), which accounts
for 0.7–1.0% of the dry weight of PS or <0.2 mol% relative
to the lipids, is required for proper lung function (11,12).
Inadequate PS is a leading cause of respiratory distress
syndrome in premature infants (13).
The native form of SP-B is a highly hydrophobic, 17 kDa
sulfhydryl-linked homodimer (14). Intramolecular disulfide
bridges formed by the remaining six cysteine residues and
a sequence similar to sphingolipid-activator proteins place
SP-B in the saposin-like protein family. However, SP-B is
significantly more lipophilic than other saposin-like
proteins, and has not been found to activate lipids for enzy-
matic modification. The hydrophobicity and disulfidedoi: 10.1016/j.bpj.2010.06.076
1774 Farver et al.bridges within SP-B make it difficult to express and purify
heterologously. Animal sources of lung surfactant are the
current standard of care therapeutically, posing a risk of
infection or immune response (15).
Given the tremendous importance of SP-B for surfactant
function, surfactant replacement methods employing simple
peptide analogs with surface-active properties have been the
focus of many investigations. N- and C-terminal peptide
fragments of SP-B, 20–25 amino acids in length, possess
significant surface activity and can restore lung compliance
in mouse models of respiratory distress (16–19). Addition-
ally, a simple peptide analog (known as KL4) based on the
hydrophilic and hydrophobic periodicity in the C-terminus
has shown clinical success (20), and peptoid analogs are
also surface-active (21). The N-terminal 25-residue peptide,
SP-B1-25, has been shown to not only improve the surface
activity of lipid mixtures, but also to be more resistant to
inhibition by the plasma protein fibrinogen compared to
the full protein (22). More recently, a chimeric construct
made up of the C- and N-terminal sequences (termed
mini-B) has shown increased activity relative to the indi-
vidual peptides and is comparable in activity to native
SP-B at similar concentrations (23). The success of this
synthetic analog suggests that both the N- and C-terminal
sequences in SP-B are important for its function and may
have complementary roles.
We recently reported that at therapeutically relevant
concentrations, both SP-B59-80 and KL4 differentially parti-
tion into lipid bilayers of varying saturation while pre-
serving a lamellar phase (24,25). The helical secondary
structures of both SP-B59-80 and KL4 in a lipid bilayer envi-
ronment vary from canonical a-helices, and both undergo
changes in helicity with varying lipid composition, suggest-
ing that structural plasticity is important to their mechanism
of action. SP-B1-25 has also been shown to possess signifi-
cant helical structure when it is associated with lipid mono-
layers and bilayers (26–28). On the basis of FTIR and CD
measurements, it has been inferred that the proline-rich
N-terminal residues of SP-B1-25 are not highly structured.
Monolayer studies have demonstrated these residues are
important to its rapid insertion into lipid films (19).
The effect that SP-B1-25 has on lipid organization and
polymorphisms has not been thoroughly investigated. The
ability of SP-B1-25 to modulate the macroscopic organiza-
tion of lipid molecules may play a functional role in main-
taining reservoirs of LS lamellar bodies near the air-water
interface (10). Here we report that SP-B1-25 can induce non-
lamellar lipid morphologies when mixed with PS lipids.
We utilized static 2H and 31P NMR, CD, DLS, TEM, and
DSC to characterize 4:1 DPPC/POPG and 3:1 POPC/
POPG lipid mixtures upon addition of varying concen-
trations of SP-B1-25. The former lipid composition was
selected to mirror the lipid composition of several model
PS studies and lucinactant, a synthetic formulation under
development for treating respiratory distress syndrome,Biophysical Journal 99(6) 1773–1782whereas the latter composition is similar to formulations
used in numerous studies of amphipathic membrane-active
peptides (29) and allows for a direct comparison of the phys-
ical properties of SP-B1-25 to SP-B59-80 and KL4. Lipid
phases enriched in either POPC/POPG or DPPC/POPG
could potentially be found in localized areas of the alveoli
during the surfactant cycle.MATERIALS AND METHODS
Synthesis of SP-B1-25 and preparation
of peptide/lipid samples
SP-B1-25 (FPIPLPYCWLCRALIKRIQAMIPKG) was synthesized via
solid-phase peptide synthesis, purified by reverse-phase high-performance
liquid chromatography, and verified by mass spectrometry (m/z ¼ 2928).
Peptide was dissolved in methanol and analyzed by amino acid analysis
for concentration (Molecular Structure Facility, University of California,
Davis). POPC, DPPC, POPG, POPC-d31, DPPC-d62, and POPG-d31 chloro-
form solutions (Avanti Polar Lipids, Alabaster, AL) were quantified by
phosphate analysis (Bioassay Systems, Hayward, CA). SP-B1-25 in meth-
anol was added to the lipid chloroform solutions resulting in P/L ratios
ranging from <1:1000 to 1:20. Samples were dried under nitrogen
at >45C, suspended in warm cyclohexane (>45C), flash frozen in
nitrogen, and lyophilized to remove residual solvent.CD experiments
CD spectra were acquired at 45C on an Aviv Model 215 (Lakewood, NJ).
Samples were prepared by hydrating lyophilized peptide-lipid powders in
10 mM HEPES buffer, pH 7.4, with 140 mM NaCl and 1 mM EDTA, to
achieve a final concentration of 36 mM SP-B1-25. Samples were extruded
through 100 nm filters (Avanti Polar Lipids) to form LUVs. Spectra of
40 mM SP-B1-25 in methanol were also collected.DSC analysis
Thermograms were collected on a VP-DSC microcalorimeter (Microcal,
Northampton, MA). Samples were prepared by solubilizing peptide-lipid
powders as above to achieve a 2.5 mM lipid concentration. The samples
were extruded and degassed.Solid-state NMR analysis
31P and 2H NMR data were collected on a 500 MHz Bruker DRX system
(Billerica, MA) with a 5 mm BBO probe. For the 31P NMR experiments,
25 kHz proton decoupling was employed. 2H NMR spectra were collected
using a quad echo sequence (90-t-90-t-acq with t ¼ 30 ms). For each
NMR sample, ~20 mg of peptide-lipid powder were placed in a 5 mm diam-
eter NMR tube and 200 mL of buffer containing 10 mM HEPES, pH 7.4,
140 mMNaCl, and 1 mMEDTA in 2H depleted water (Cambridge Isotopes,
Andover, MA) were added. The hydrated dispersions were subjected to five
freeze-thaw cycles to form MLVs. DePaking of NMR data was accom-
plished with previously published algorithms that simultaneously dePake
and determine macroscopic ordering in partially aligned lipid spectra using
Tikonov regularization (30). Assignments of 2H resonances were made
based on Petrache et al. (31).DLS measurements
DLS measurements were performed using a Brookhaven 90Plus/BI-MAS
ZetaPALS spectrometer with BI-9000AT Digital Autocorrelator and
0
-
3 5    
10    
SP-B1-25 Lipid Interactions 17759KDLSW data acquisition software. The instrument was operated at
a wavelength of 659 nm over a temperature range of 25–45C. The samples
contained a 1 mM suspension of 4:1 DPPC/POPG MLVs.[
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TEM images of 4:1 DPPC/POPG MLVs were captured using a Hitachi
H-7000 transmission electron microscope operated at 75 kV with a Soft-
Imaging System MegaViewIII and AnalySIS digital camera (Lakewood,
CO). Samples were prepared as above and contained a 1 mM suspension of
4:1 DPPC/POPG MLVs. Sample grids were prepared by negative staining.-30    
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FIGURE 1 (Top) CD spectra at 45C of SP-B1-25 at a P/L molar ratio of
1:100, 1:33, and 1:20 averaged together in 4:1 DPPC/POPG (black solid
line) and in 3:1 POPC/POPG (gray solid line). The CD lineshapes for the
individual P/L molar ratios are identical. A spectrum of SP-B1-25 dissolved
in MeOH is shown for comparison (dashed line). The final peptide concen-
tration was ~40 mM in all samples. (Bottom) DSC scans for 4:1 DPPC/
POPG LUVs with SP-B1-25 at the indicated molar peptide percentages.
The onset of phase separation is apparent at a P/L ratio of 1:200 andRESULTS
SP-B1-25 adopts a stable, primarily helical
structure in the presence of lipid vesicles
CD spectroscopy was utilized to investigate the conforma-
tion of SP-B1-25 in the presence of 4:1 DPPC/POPG and
3:1 POPC/POPG unilamellar lipid vesicles (Fig. 1 A). The
CD spectra at 45C are identical for the two lipid environ-
ments and have features characteristic of helical secondary
structure, with minima at 208 and 222 nm. Standard decon-
volution analysis (32) gives secondary structure estimates of
60% a-helix, 30–35% random coil, and <10% b-sheet for
SP-B1-25 interacting with phospholipid LUVs. These find-
ings are consistent with results from previous FTIR studies
of isotopically enriched SP-B1-25 in POPG, which con-
cluded that the peptide forms a well-structured a-helix
from residues 8–22 and a b-sheet conformation in the first
six residues (27). The CD spectra for the peptide in the lipid-
containing samples are identical for both lipid mixtures
and over a concentration range of 1–5 mol% SP-B1-25. A
CD spectrum obtained for SP-B1-25 in methanol (dashed
line), where the peptide is more helical, is also shown for
comparison.continues with increasing amounts of peptide.DSC shows that SP-B1-25 decreases lipid
miscibility
Shown in Fig. 1 B are DSC thermograms for 4:1 DPPC/
POPG LUVs containing varying molar percentages of
SP-B1-25. Samples for DSC measurements had the same
lipid compositions as those used for the NMR investigations
described below, i.e., they included deuterated lipids
(DPPC-d62), the presence of which is known to lower
the lipid phase transition temperature. The main phase
transition temperature for the 4:1 DPPC/POPG sample is
observed at 32C. At 0.5 mol% SP-B1-25, a higher tempera-
ture shoulder appears at ~34C in the thermogram. The
intensity of this shoulder grows as the concentration of pep-
tide increases. At 1.5 mol% peptide, two separate melting
events are resolved with Tm values of 31
C and 34C, sug-
gestive of lipid demixing or domain separation. This effect
on the DSC thermogram is similar to that previously noted
for the lung surfactant peptides KL4 (33) and SP-B59-80 (24).Similar effects on the DSC thermograms for 7:3 DPPC-d62/
POPG and 7:3 DPPC/POPG-d31 with and without 3.5%
SP-B8-25 (by weight) have been observed (34). From DSC
data alone, one cannot distinguish whether the two transi-
tions result from the formation of separate POPG-enriched
and POPG-depleted DPPC lipid domains or whether the
different melting temperatures arise from phase separation
of bulk lipids and peptide-associated lipids (35) or a combi-
nation of the two, such as DPPC-peptide separation from
DPPC-POPG domains.2H NMR spectra indicate that SP-B1-25 decreases
PC/PG lipid miscibility and induces an isotropic
phase, particularly for PC lipids
To obtain a molecular-level view of how SP-B1-25 modulates
lipid organization and mixing, solid-state 2H NMR spectra
of both saturated and unsaturated lipid mixtures containingBiophysical Journal 99(6) 1773–1782
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FIGURE 2 Deuterium NMR spectra as a function of temperature for
(top) 4:1 DPPC-d62/POPG MLVs and (bottom) DPPC/POPG-d31 MLVs
with SP-B1-25 added at the indicated molar percentages.
1776 Farver et al.varying mol% SP-B1-25 were obtained and analyzed.
Samples containing either deuterated PC or PG were
prepared, which allowed the monitoring of individual lipid
components. Fig. 2 shows stack plots of 2H NMR data
obtained for 4:1 DPPC/DOPG samples with varying mol%
SP-B1-25 over a temperature range of 26
C to 40C. In the
absence of peptide, both the DPPC and POPG components
are observed to melt at similar temperatures. The phase
transition temperatures for DPPG and POPG were deter-
mined from sigmoidal fits to first-moment analyses of
spectra collected between 22C and 44C. The phase
transition temperature determined for deuterated DPPC is
slightly lower (30.8C) than that for deuterated POPG
(32.8C). This difference is likely due to a larger relative
percentage of the fatty acyl chains being deuterated in
the DPPC-d62-containing sample compared to that of the
POPG-d31-containing sample (80% vs. 10%) (36). For non-
peptide-containing samples, the spectra at intermediate
melting temperatures, from 26 to 32C, have lineshapes
that are a superposition of gel phase and liquid crystalline
phase spectra, consistent with the broad asymmetric DSC
thermogram obtained for this lipid mixture. The addition
of 1 mol% SP-B1-25 increases the phase transition of the
DPPC lipids, with the melting midpoint determined to be
34.3C, whereas the melting temperature of the POPG
component is not altered. These results are consistent with
the DSC thermograms, where a shoulder at 34C is detected
for this concentration of SP-B1-25, and they suggest someBiophysical Journal 99(6) 1773–1782demixing of DPPC from the mixture on addition of
SP-B1-25. Of more interest, however, is the phase behavior
seen with 3 mol% SP-B1-25. At this peptide concentration,
DPPC-d62 spectra from 22
C to 32C are dominated by an
isotropic peak that changes abruptly to a gel phase spectral
lineshape over 34–36C, followed by the formation of a
liquid crystalline lamellar phase at 38–40C. The lamellar
phase spectrum at 38C has significant signal intensity at
the parallel edges of the lineshape relative to spectra at
higher temperatures, which is consistent with more-rounded
vesicles at this temperature. At higher temperatures the
vesicles elongate in the magnetic field, leading to a loss
of signal at the parallel edges, as is commonly seen with
lipid mixtures at these high magnetic field strengths. With
5 mol% SP-B1-25, an isotropic phase is observed for
DPPC-d62 over the entire 26–40
C temperature range with
the appearance of an anisotropic phase at 40C. Spectra
acquired up to 44C contained a significant isotropic
component (see Fig. S1 in the Supporting Material). The
POPG-d31 spectra show less of an alteration in lipid
behavior at 5 mol% peptide concentrations, but they are
affected nonetheless. At 5 mol% SP-B1-25, the spectra for
POPG-d31 show trends very similar to those observed for
DPPC-d62 in the presence of 3 mol% SP-B1-25 (Fig. 2).
Given these observations, it is likely that the addition of
peptide causes DPPC and POPG to partially demix over
the phase transition temperatures with addition of peptide,
particularly at physiologic temperatures. This is in agree-
ment with the DSC data presented above. Of interest, the
cationic peptide has a larger effect on the phase behavior
of the zwitterionic DPPC than the anionic POPG, as the
isotropic DPPC spectra suggest that the peptide preferen-
tially interacts with the DPPC-enriched domain.
Differences in the peptide’s effects on DPPC and POPG
lipid morphology in DPPC/POPG lipid mixtures may be
attributed to different interactions of the peptide with the
lipid headgroups, differences in partitioning due to their
differing fatty acid saturation, or both. A third major lipid
component of lung surfactant is POPC, which has a molec-
ular structure intermediate between DPPC and POPG.
We also investigated the effects of SP-B1-25 on the thermo-
tropic and phase behavior of 3:1 POPC/POPG mixtures. To
compare the phase transition behavior of POPC/POPG
mixtures upon addition of SP-B1-25, we collected
2H NMR
data for 3:1 POPC/POPG samples containing either POPC-
d31 or POPG-d31 over the temperature range of the phase
transition for the monounsaturated lipids, which is ~40C
lower than the DPPC/POPG mixture (Fig. S2). A compar-
ison of the trends for the POPC/POPG samples with the
DPPC/POPG samples near the respective phase transition
temperatures of the lipid mixtures indicates that these mix-
tures behave very similarly, with the PC lipids being more
affected by the addition of SP-B1-25 and with both systems
showing the induction of an isotropic phase by the peptide.
The phase transition observed for deuterated POPC is at
SP-B1-25 Lipid Interactions 1777a slightly lower temperature (midpoint of 4.3C) than that
for deuterated POPG (3.0C) because a larger percentage
of the lipids are deuterated in the POPC-d31-containing
sample (75% vs. 25%). The addition of 1 mol% SP-B1-25
increases the phase transition temperature of the POPC
lipids by almost 6C, with the melting midpoint at 1.2C.
In contrast, the transition temperature of the POPG lipids
increases only 3.1C, with a midpoint of 0.1C. With
3 mol% SP-B1-25, the spectra for the POPC-d31 lipids
exhibit an isotropic peak at temperatures below the Tm of
the lipids, which coalesces into a gel phase lineshape near
the phase transition temperature (2C to 4C), followed
by the formation of a liquid crystalline lamellar phase at
higher temperatures. With 5 mol% SP-B1-25, an isotropic
phase is observed for POPC-d31 over the entire low temper-
ature range (6C to 4C), with the appearance of an aniso-
tropic lineshape beginning at 4C. The POPG-d31 spectra
show less of an alteration in lipid behavior at similar peptide
concentrations, but they also show the appearance of an
isotropic peak at lower temperatures and higher peptide
concentrations. The spectra for POPG-d31 in a sample con-
taining 5 mol% SP-B1-25 show trends very similar to those
observed for POPC-d31 in the presence of 3 mol% SP-B1-25.
From the 2H NMR data it is clear that lipid headgroup
composition (PC versus PG) plays a role in determining
the phase behavior of the individual lipids in mixtures
containing SP-B1-25. The effects of the peptide on lipid
morphology are also determined by the degree of saturation
in the lipids. This can clearly be seen by comparing the
dynamics of each of the lipids in the DPPC/POPG and
POPC/POPG mixtures at the average mammalian physio-
logic temperature of 38C (Fig. 3). At this temperature,
the DPPC lipids are most affected by the addition of peptide
and exhibit isotropic phase behavior at 5 mol% SP-B1-25.
Even at 3 mol% peptide the DPPC lipids are in exchange-40-2002040
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FIGURE 3 Deuterium and phosphorous NMR spectra taken at 38C. (A)
2H spectra of 4:1 DPPC-d62/POPG MLVs, (B)
2H spectra 4:1 DPPC/
POPG-d31 MLVs, (C)
31P spectra of 4:1 DPPC-d62/POPG MLVs, (D)
2H
spectra of 3:1 POPC-d31/POPG MLVs, (E)
2H spectra of 3:1 POPC/
POPG-d31 MLVs, and (F)
31P spectra of 3:1 POPC-d31/POPG MLVs with
SP-B1-25 at the indicated molar percentages.between lipid phases, as evidenced by the broadened line-
shape. In contrast, the POPC and POPG lipids exhibit
a lamellar lineshape even at 5 mol% peptide, although
the lineshape is somewhat broadened, suggesting that an
exchange between lipid phases may be occurring.31P NMR spectra are consistent with dynamic
exchange between the isotropic and lamellar
phases on a kHz timescale
At 11.7 T, phospholipid phosphorus chemical shift anisot-
ropy tensors are more than an order of magnitude smaller
than the deuterium quadrupolar coupling for a methylene
group. Thus, static 31P NMR spectra are more sensitive to
slower motions, such as exchange between lipid phases.
31P NMR spectra at 38C for 3:1 POPC/POPG and 4:1
DPPC/POPG MLVs containing various concentrations of
SP-B1-25 are also shown in Fig. 3. Because the data were
collected on a 500 MHz NMR spectrometer, macroscopic
alignment of the vesicles occurred, causing a decrease in
the downfield features (parallel edges) of the lamellar line-
shapes for the phospholipid dispersions. However, the
perpendicular edges of the PG and PC lipid powder line-
shapes (at 11 and 15 ppm, respectively) can be clearly
distinguished due to slight differences in the average orien-
tation of their respective phosphate headgroups relative to
the plane of the lipids (24,25). In the DPPC/POPG mixtures,
the addition of 3 mol% SP-B1-25 leads to the appearance of
an isotropic peak concurrent with a loss of intensity at the
perpendicular edge for DPPC. At 5 mol% peptide, the
isotropic peak dominates the spectrum and the perpendic-
ular edge of the POPG lineshape is also significantly less
intense, consistent with exchange between a lamellar phase
and an isotropic phase. In the POPC/POPG mixtures, the
addition of peptide has less of an effect on the 31P lineshapes
at 38C; an isotropic peak is not observed. However, there is
sufficient lipid exchange to observe altered lineshapes in
samples containing 3 and 5 mol% peptide. 31P spectra as
a function of temperature for both DPPC/POPG and
POPC/POPG are provided in Fig. S3. Significant isotropic
components are observed in the spectra near the phase
transition temperatures of the lipid mixtures on addition of
SP-B1-25, consistent with the
2H NMR data. The persistence
of an isotropic peak in the 31P spectra at temperatures where
2H spectra are anisotropic (e.g., compare 2H and 31P spectra
for DPPC/POPG samples containing 3 mol% SP-B1-25 in
Fig. 3) is consistent with motions on a kHz timescale
contributing to the averaging of the 31P lineshapes.Addition of SP-B1-25 may lead to a cubic or fluid
isotropic phase via vesicle fusion
The appearance of isotropic lineshapes in the 31P and 2H
NMR spectra upon addition of peptide is consistent with
the formation of micellar, cubic, or fluid isotropic lipidBiophysical Journal 99(6) 1773–1782
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1778 Farver et al.phases (37,38). To determine the relative sizes of the lipid
assemblies and distinguish which lipid polymorphism
results from the addition of SP-B1-25, we examined the
effects of peptide addition on DPPC/POPG vesicles by
DLS and EM. DPPC/POPG vesicles exhibit a broad range
of vesicle sizes, with an average size of ~500 nm. Addition
of SP-B1-25 leads to the formation of larger vesicles in a
concentration-dependent manner (Fig. S4). No vesicles
< 150 nm are seen in the peptide-containing samples, ruling
out micelle formation, and a rise in vesicles > 4000 nm is
observed. The DLS instrument setup is unable to determine
vesicle sizes above 10,000 nm, but a clear trend toward
larger sizes is observed for samples containing higher mol%
SP-B1-25. Of interest, the samples containing higher peptide
concentrations are visibly less opaque, ruling out the possi-
bility that the DLS data are affected by a decrease in sensi-
tivity due to sample turbidity. Examination of lipid
assemblies by EM also indicates that the addition of
SP-B1-25 leads to the appearance of larger interconnected
or fused vesicles (Fig. S4). These observations are consis-
tent with a cubic or fluid isotropic phase via vesicle fusion.0
0 5 10 15
Carbon
FIGURE 4 Order parameter profiles for the sn-1 chain of (top) DPPC-d62
in 4:1 DPPC-d62/POPG and (bottom) POPG-d31 in 4:1 DPPC/POPG-d31
MLVs at 44C with SP-B1-25 at the indicated molar percentages.SP-B1-25 partitions at the lipid interface in lipid
lamellae
By analyzing the 2H NMR spectra of the lipid mixtures
above their lamellar phase transition temperatures, one
can monitor the effect of SP-B1-25 on lipid acyl chain
dynamics in the fluid phase. From these effects, one can
infer the partitioning depth of SP-B1-25 into the lipid bila-
yers. Lipid acyl chain order parameters were determined
as previously described (25). Since our lipid samples show
some degree of alignment in the magnetic field, we decon-
voluted the spectra using a Tikonov regularization proce-
dure to account for vesicle alignment. The resulting order
parameter profiles for the sn-1 chain in mixtures of
DPPC-d62/POPG and DPPC/POPG-d31 at 44
C containing
various levels of SP-B1-25 are graphed in Fig. 4; data for
POPC-31/POPG and POPC/POPG-d31 samples are pre-
sented in Fig. S5. The addition of SP-B1-25 results in
a decrease in order parameters with increasing SP-B1-25
concentrations for all the lipids in the two types of mixtures.
A distinct drop in the order parameters is observed upon
addition of 5 mol% SP-B1-25. From the order parameter
profiles, it can be seen that the methylenes toward the center
of the bilayers are more affected than those in the plateau
region. This behavior is similar to changes observed in lipid
order upon addition of antimicrobial peptides (29,39,40)
and suggests that the amphipathic helix of SP-B1-25 parti-
tions near the lipid headgroups.DISCUSSION
The ability of SP-B to affect the organization and structures
of lipid assemblies on the micron scale is well recognizedBiophysical Journal 99(6) 1773–1782(12). These effects are particularly striking given the low
physiologic concentration of SP-B, with 400–800 lipid
molecules per protein monomer (9). Much of the effort
toward developing synthetic replacements of PS has been
focused on identifying which sequences in the highly hydro-
phobic SP-B are most critical for modifying lipid properties
in PS. There is now a general consensus that the N- and
C-termini of the protein are the most active portions of the
protein (16,18,19). In this study, we focused on the effects
of the N-terminal 25-residue peptide, SP-B1-25, on lipid
dynamics and morphology. We find that at relatively low
concentrations, SP-B1-25 has a marked effect on lipid
morphology.
SP-B1-25 is recognized as a surface-active and function-
ally important domain within SP-B, but the molecular
mechanisms underlying its activity, specifically its effects
on lipid organization and dynamics in bulk PS, have thus
far not been fully elucidated. Previous studies focused
on its surface properties via Langmuir monolayer studies
of surface tension, lipid adsorption at the air-water interface,
surface film stability, and film structure as a function of
surface pressure (41–43). These studies are particularly
germane given the role of PS in lowering surface tension
and the natural air-water interface established within the
lung for oxygen exchange. However, EM studies of alveolar
surfaces indicate that type II pneumocytes secrete surfactant
into a thin aqueous layer with an average thickness of
SP-B1-25 Lipid Interactions 17790.2 mm, with the bulk of the PS lipids and proteins seques-
tered in the aqueous subphase (44). Although SP-B has been
demonstrated to promote the rapid transfer of phospholipids
between the bulk aqueous phase and the air-water interface,
it is not established whether SP-B itself partitions at the
interface to accomplish this. For these reasons, we examined
the effects of SP-B1-25 on lipid dynamics and organization in
aqueous suspensions. Our observation by NMR of the coex-
istence of an isotropic phase in exchange with a lamellar
phase on addition of SP-B1-25 to aqueous dispersions of
DPPC/POPG and POPC/POPG mixtures is in good agree-
ment with the proposed role of SP-B in aiding lipid transfer
within the aqueous subphase.
Although isotropic NMR spectra for lipids are generally
associated with the formation of small lipid micelles, which
have correlation times shorter than the NMR timescale,
other lipid polymorphisms can lead to isotropic lineshapes
if the dynamics of the lipids allow individual lipid mole-
cules to sample a broad array of orientations relative to
the magnetic field on a fast enough timescale. In particular,
cubic and fluid isotropic lipid phases are also consistent with
isotropic NMR spectra. DLS results show that the lipid
vesicle assemblies become larger rather than smaller upon
peptide addition, suggesting vesicle fusion rather than
micelle formation. To confirm this, we collected EM data
on DPPC/POPG lipid mixtures prepared with SP-B1-25.
Clear fusion of the vesicles and an increase in average
vesicle size is observed relative to pure lipid mixtures.
However, it appears the vesicle structures are still somewhat
lamellar in nature within the resolution of this technique.
This suggests that the observation of an isotropic phase by
NMR is due to fast exchange of the lipids between lamellae
facilitated by SP-B1-25. Closer inspection of the
2H and 31P
NMR spectra support a model of SP-B1-25-supported
exchange of lipids between lamellae on a kHz timescale.
The 2H quadrupolar interaction is an order of magnitude
larger than the 31P chemical shift anisotropy, allowing the
concurrent observation of an isotropic lineshape in the 31P
spectrum and a lamellar lineshape in the 2H spectrum for
a particular sample at temperatures where lipid exchange
is intermediate between the timescales of these two interac-
tions. This behavior is consistent with multilayer structures
observed in native PS by EM and the induction of cubic
phases in POPE suspensions by SP-B and SP-C (45). Addi-
tionally, EM (46), atomic force microscopy (47), and
neutron reflection (48) studies have demonstrated that the
film formed by PS at an air-water interface is thicker than
a monolayer with an aqueous, multilayer, surface-associated
surfactant reservoir. This reservoir and the secreted surfac-
tant-containing lamellar bodies have multilayer structures
that are dependent on SP-B. Our results suggest that SP-
B1-25 may be critical for the juxtaposition of and exchange
between lipid lamellae in PS.
SP-B1-25 may play a role not only in the organization of
PS lipid assemblies, but also in lipid miscibility. DSC and2H NMR indicate that some lipid phase separation is
observed upon addition of the peptide to either DPPC/
POPG or POPC/POPG mixtures. Our NMR results show
that SP-B1-25 enhances the transfer of DPPC between lipid
lamellae relative to POPC and POPG at physiologic temper-
atures, although there is some transfer of POPC and POPG
lipids as well. Alterations in 31P lineshapes can be seen
at lower temperatures for samples containing as little as
1 mol% SP-B1-25. Motional averaging becomes more dra-
matic at 3 mol% SP-B1-25 and the extent of averaging is
dependent on both the Tm of the lipid mixtures and the iden-
tity of the phospholipid headgroups. In particular, 2H NMR
spectra of both POPC and DPPC species exhibit isotropic
lineshapes below the Tm of the POPC/POPG and DPPC/
POPG mixtures, respectively. 31P spectra indicate that the
POPG species is also isotropic at low temperatures, but
returns to a lamellar phase at lower temperatures than the
PC lipids. At 5 mol% SP-B1-25, the trend is even more
dramatic. The 2H NMR spectra for POPG-d31 and POPC-
d31 are isotropic below 2C and 6C, respectively in
POPC/POPG mixtures. In DPPC/POPG the resolution
back to a lamellar lineshape is seen for POPG-d31 at
~34C, but DPPC-d62 lineshapes remain isotropic below
40C. This suggests that SP-B1-25 has an effect on lipid
miscibility, particularly near the Tm of the lipid mixtures.
This is especially relevant for PS, which has a Tm of
~35C, similar to the DPPC/POPG mixture. Although phys-
iologic levels of SP-B are much lower, at 0.1–0.2 mol%,
our observation that 1 mol% SP-B1-25 can lead to significant
averaging of the majority of the phospholipids in our mix-
tures suggests that even lower percentages of peptide could
lead to significant transfer of lipids between lamellae. The
ability of SP-B1-25 to nucleate a cubic or fluidic lipid phase,
particularly for lipid mixtures containing DPPC, suggests
a role for the N-terminus of SP-B in the packing of lipid
lamellae into surfactant lamellar bodies or in stabilizing
multilayer structures at the air-liquid interface. Our observa-
tion that at physiologic temperature the dynamics of DPPC
lipid moiety are much more affected by SP-B1-25 is particu-
larly intriguing, and suggests that SP-B may enhance the
exchange of DPPC between lipid lamellae while POPG
and other lipids remain within a planar lipid structure. It has
been postulated DPPC may be specifically enriched at the
air-water interface by PS proteins (8), and this result gives
credence to that model.
Although both the N- and C-termini of SP-B have been
demonstrated to have some efficacy via both in vivo and
in vitro assays, the exact boundaries of the active sequences
and their effects on lipid organization at the molecular level
have not been fully delineated. Our finding that at relatively
low concentrations SP-B1-25 has a marked effect on lipid
morphology is in contrast to previous studies of SP-B8-25
(34), the C-terminus (both SP-B59-80 (24) and SP-B63-78
(49)), and a functional mimic of the C-terminus, KL4 (25).
We also note that whereas an isotropic phase has not beenBiophysical Journal 99(6) 1773–1782
FIGURE 5 Model of SP-B1-25 interacting with (top left) anionic lipids
and (bottom left) zwitterionic lipids, and (right) inducing a fluid isotropic
phase in DPPC-rich regions.
1780 Farver et al.observed for lipid assemblies containing SP-B8-25 (34), it
has been observed for lipid samples containing full-length
SP-B at a concentration of ~2 mol% (50,51). This indicates
a specific role for the highly conserved, very hydrophobic
first seven amino acids (FPIPLPY) as well as the amphi-
philic helix from residues 8–22 in lipid association and
remodeling. This is consistent with recent findings that
the activity of a chimeric construct containing the N- and
C-terminal domains of SP-B (mini-B) has superior activity
upon addition of this sequence (52), and that mutations in
this sequence lead to poorer reinsertion of lipids into an
expanding air-water interface (19). Recent studies of surfac-
tant systems at the air-water interface have also demon-
strated that the hydrophobic N-terminus is important for
stabilizing lipid nanosilos in association with POPG-
enriched areas of a DPPC/POPG monolayer (53).
Molecular-dynamics simulations of SP-B1-25 in DPPC
monolayers suggest that the most likely equilibrium con-
formation is with the a-helix in SP-B1-25 parallel to the
interface (54). FTIR studies indicate that the first seven
hydrophobic residues adopt a b-sheet conformation that
penetrates into the interior of the lipid bilayers, with resi-
dues 8–22 forming an amphiphilic helix at the lipid bilayer
interface (27). Our CD measurements are consistent with
these studies and indicate that the overall structure of
SP-B1-25 is relatively invariant with lipid composition and
peptide concentration. The effects of SP-B1-25 on lipid
acyl chain order parameters in the lamellar phase (Fig. 4)
are also consistent with the peptide partitioning at the lipid
interface. However, subtle differences in the effects of
SP-B1-25 on acyl chain order within PG versus PC lipids
suggest differential partitioning. Specifically, the PG acyl
chains become more disordered than PC acyl chains in the
lamellar phase upon addition of peptide to DPPC/POPG
and POPC/POPG mixtures. Increased order in the PC acyl
chains can result from either a more peripheral association
of the peptide with the bilayers via electrostatic interactions
(55) or the peptide partitioning more deeply into the bilayer
(24,25,56). SP-B1-25 has a relatively high percentage of
hydrophobic residues relative to other amphipathic peptides,
as do all the active PS peptides, and it has a highly hydro-
phobic N-terminus, which would favor deeper partitioning.
This observation, combined with the observed greater
effects of SP-B1-25 on the overall organization of the PC
lipids, suggests that SP-B1-25 may partition more deeply
into PC-enriched lipid domains while remaining more
surface-associated in PG-enriched lipid domains as a conse-
quence of the differences in the charge states at the lipid
interfaces (Fig. 5). This model is consistent with enzyme-
linked immunosorbent assays performed using SP-B recon-
stituted in anionic and zwitterionic bilayers (57), which
revealed that SP-B was more immunoreactive to water-
soluble antibodies when it was reconstituted into anionic
lipid bilayers. The deeper partitioning of SP-B1-25 into
PC-enriched lipids would lead to negative curvature strain,Biophysical Journal 99(6) 1773–1782which can induce lipid flipping and the formation of a cubic
or fluid isotropic phase, or, at the air-water interface,
enhanced adsorption of lipids to the surface monolayer
from underlying lipid bilayers. The ability of SP-B1-25 to
fuse lipid lamellae via this mechanism, particularly those
enriched in DPPC, suggests a molecular mechanism for
how the N-terminus of SP-B can facilitate packing of lipid
lamellae into surfactant lamellar bodies or stabilize multi-
layer structures at the air-liquid interface. Further structural
studies will assist in elucidating the mechanism by which
the N-terminus modulates lipid organization in both the
aqueous subphase and in association with the monolayer
at the air-water interface.CONCLUSIONS
In this study we found that SP-B1-25 retains a constant
secondary structure when associated with lipids and causes
the formation of fluid isotropic lipid phases, particularly for
DPPC-containing lipid mixtures at physiologic tempera-
tures. These findings can be compared with our previous
CD and solid-state NMR studies on C-terminal SP-B
peptides, where, in contrast, we found that the helical pitch
of the peptide changed as the lipid milieu was altered from
saturated PC to unsaturated PC, whereas there was no effect
on the lipids (i.e., they remained in the lamellar mesophase).
These contrasting effects suggest that the N- and C-termini
of SP-B have complementary roles in trafficking of PS
lipids. With the findings presented here and elsewhere,
a more thorough molecular model is established that pro-
vides insights into how these small peptides modulate lipid
properties that can drive the development of future SP-B
mimetics. The unique interplay observed for the N- and
C-termini of SP-B among lipid moieties, peptide penetra-
tion, peptide structure, and lipid polymorphisms could
explain the unique properties of SP-B in the dynamic lung
SP-B1-25 Lipid Interactions 1781environment. The synergism between these peptides is the
focus of our ongoing work.SUPPORTING MATERIAL
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